Inspect media for physical defects (e.g., cracking, hemolysis, freezing, contamination, or incorrect volume).
M22-A3 defines clear responsibilities for all parties involved:
The CLSI M22-A3 standard remains a foundational document for quality assurance in clinical microbiology. By distinguishing between exempt and non-exempt media, it allows laboratories to maximize operational efficiency without compromising patient safety or diagnostic accuracy. Properly implementing this standard ensures that the culture media used for patient testing is consistently reliable, sterile, and biologically reactive.
: Ensure your Lab SOPs reflect the current M22-A3 standards to avoid "over-testing" exempt media. AI responses may include mistakes. Learn more clsi m22a3 pdf
Perhaps the most important caveat for US laboratories today is the regulatory status of CLSI M22-A3. While the standard remains technically valid and is retained in CLSI’s library because of its historical value to the laboratory community, .
: These are common, highly stable media types (like Blood Agar or MacConkey Agar) that have a proven track record of high quality from manufacturers. For these, laboratories can rely on the manufacturer's QC certificate rather than performing full in-house retesting, provided the lab verifies the storage conditions and physical integrity.
Understanding CLSI M22-A3: The Standard for Quality Control of Microbiological Culture Media Inspect media for physical defects (e
M22‑A3 is technically considered valid as of October 2022, and because of its value to the laboratory community, CLSI retains it in its library even though it is no longer actively reviewed through CLSI’s consensus development process.
Provide a or Quality Control Certificate with every shipment, explicitly stating compliance with CLSI M22-A3. User Responsibilities: What the Laboratory Must Still Do
Authorized, copyrighted copies of the should be acquired directly through the official CLSI online shop or authorized medical literature distributors. Utilizing unauthorized PDF hosting sites can lead to security risks, and more importantly, may result in using outdated or altered versions of the standard, which compromises laboratory compliance. Summary of Best Practices for Media Quality Control Properly implementing this standard ensures that the culture
Includes new recommendations for QC of media used to recover difficult-to-grow pathogens. Laboratory Inspection Requirements
Accessing the official PDF document allows laboratory directors, managers, and QA officers to:
Inspect media for physical defects (e.g., cracking, hemolysis, freezing, contamination, or incorrect volume).
M22-A3 defines clear responsibilities for all parties involved:
The CLSI M22-A3 standard remains a foundational document for quality assurance in clinical microbiology. By distinguishing between exempt and non-exempt media, it allows laboratories to maximize operational efficiency without compromising patient safety or diagnostic accuracy. Properly implementing this standard ensures that the culture media used for patient testing is consistently reliable, sterile, and biologically reactive.
: Ensure your Lab SOPs reflect the current M22-A3 standards to avoid "over-testing" exempt media. AI responses may include mistakes. Learn more
Perhaps the most important caveat for US laboratories today is the regulatory status of CLSI M22-A3. While the standard remains technically valid and is retained in CLSI’s library because of its historical value to the laboratory community, .
: These are common, highly stable media types (like Blood Agar or MacConkey Agar) that have a proven track record of high quality from manufacturers. For these, laboratories can rely on the manufacturer's QC certificate rather than performing full in-house retesting, provided the lab verifies the storage conditions and physical integrity.
Understanding CLSI M22-A3: The Standard for Quality Control of Microbiological Culture Media
M22‑A3 is technically considered valid as of October 2022, and because of its value to the laboratory community, CLSI retains it in its library even though it is no longer actively reviewed through CLSI’s consensus development process.
Provide a or Quality Control Certificate with every shipment, explicitly stating compliance with CLSI M22-A3. User Responsibilities: What the Laboratory Must Still Do
Authorized, copyrighted copies of the should be acquired directly through the official CLSI online shop or authorized medical literature distributors. Utilizing unauthorized PDF hosting sites can lead to security risks, and more importantly, may result in using outdated or altered versions of the standard, which compromises laboratory compliance. Summary of Best Practices for Media Quality Control
Includes new recommendations for QC of media used to recover difficult-to-grow pathogens. Laboratory Inspection Requirements
Accessing the official PDF document allows laboratory directors, managers, and QA officers to: